baber/WOPTO huggingface dataset:
Patent IL-62760-A0 (IL)
Title: Stage lighting control system
IPC: H05B37/02
Filed: 1981-04-30
Abstract: A stage lighting control system having a main processor unit and a portable desk controller, wherein a local microprocessor is provided in the portable desk controller to scan the dimmer control contacts in the desk and to transmit changed state control data to the main processor as an asynchronous serially coded signal on a low capacity link which enables the controller to be conveniently located remote from the main processor. Changed display data is developed by a visual display unit (V.D.U.) interface in the main processor for transmission on the low capacity link as standard composite video to a V.D.U. at the desk. Output to the dimmers circuitry is through an expansible plurality of output channel processors controlling groups of dimmers for efficient data formatting. Lighting level information is recorded in accordance with a channel code, patching means being provided to enable differing arrangements of dimmers circuitry to be controlled in accordance with the recorded lighting level information.
Patent IL-68791-A0 (IL)
Title: Sulfonylureas and sulfonylthioureas,their preparation and their use as herbicides and plant growth regulants
IPC: C07D251/00
Filed: 1983-05-26
Abstract: The invention relates to novel suylfonylureas of the formula I <IMAGE>  (I)  wherein R1 is hydrogen or C1-C5alkyl, R2 and R3, each independently of the other, are hydrogen, C1-C5alkyl, C1-C5alkoxy, C1-C5alkylthio, C1-C5haloalkyl, halogen, C1-C5haloalkylthio, C1-C4alkylamino, C1-C4dialkylamino, an alkoxyalkyl group or alkoxyalkoxy group, each containing not more than 6 carbon atoms, Z is oxygen or sulfur, E is -CH= or -N=, and Q is an unsubstituted or substituted 6-membered heterocyclic radical containing 2 to 3 nitrogen atoms and bound through a carbon atom, and the salts thereof. A process for the preparation of the novel compounds and the use thereof are also described. The compounds of formula I can be used in the form of agriculturally useful compositions for controlling weeds and/or for selectively influencing plant growth.
Patent IL-75274-A0 (IL)
Title: Body hugging instrumentation vest
IPC: A61B5/0275
Filed: 1985-05-22
Abstract: A vest (12) for positioning medical instrumentation about the human or animal torso (10) provides ambulatory monitoring of patient cardiac functions or administration of medication or therapy with reasonable freedom of movement while maintaining precise positioning of the instrumentation relative to the torso. The vest typically includes a sheet (14) of a dimensionally rigid material such as a low density polymer tailored to fit between neck (18) and hips (20) and to surround the torso, terminating on the back. Straps (34, 36, 44, 46) are provided to fasten the sheet ends together at the back and suspend it from the shoulders (48, 50). The vest may also be instrument to function as a transducer itself to detect chest expansion for heart or lung volume monitoring.
Patent IL-79534-A0 (IL)
Title: Synthetic peptides being grf analogs and pharmaceutical compositions containing them
IPC: A61K35/74
Filed: 1986-07-28
Abstract: Human pancreatic GRF and the hypothalamic GRFs for the human and several other mammalian species were earlier characterized and synthesized. The invention provides synthetic peptides which are potent stimulators of the release of pituitary GH in animals, including humans, and which have the formula: R<sub>1</sub>-R<sub>2</sub>-R<sub>3</sub>-Ala-R<sub>5</sub>-R<sub>6</sub>-R<sub>7</sub>-R<sub>8</sub>-R<sub>9</sub>-R<sub>10</sub>-R<sub>11</sub>-R<sub>12</sub>-R<sub>13</sub>-Leu-R<sub>15</sub>-GIn-Leu-R<sub>18</sub>-R<sub>19</sub>-R<sub>20</sub>-R<sub>21</sub>-Leu-Leu-Gln-Glu-R<sub>26</sub>-R<sub>27</sub>-R<sub>28</sub>-Arg-Y wherein R, is Tyr, D-Tyr, Met, Phe, D-Phe, Leu, His or D-His, which has either a C<sup>a</sup>Me or N<sup>a</sup>Me substitution or is unsubstituted; R<sub>2</sub> is Ala or D-Ala; R, is Asp or D-Asp; R<sub>5</sub> is lie or Leu; R<sub>6</sub> is Phe or Tyr; R, is Ser or Thr; R<sub>5</sub> is Ser, Asn, Thr or Gin; R, is Ala or Ser; R<sub>10</sub> is Tyr, Phe or Leu; R<sub>11</sub> in Arg, Om or Lys; R,, is Arg, Om or Lys; R<sub>13</sub> is Ile, Leu, Phe or Val; R<sub>15</sub> is Gly or Ala; R<sub>18</sub> is Ala or Ser; R<sub>19</sub> is Ser or Ala; R<sub>20</sub> is Arg, Om or Lys; R<sub>21</sub> is Arg, Om or Lys; R<sub>26</sub> is Leu, Ile, Val or Phe; R<sub>27</sub> is Nle, Nva or a natural amino acid; R<sub>28</sub> is Ala, Leu, Asn, Gin, or Ser; and Y is OH or NH<sub>2</sub>; provided however that at least four of the residues constituting R<sub>s</sub>, R<sub>5</sub>, R<sub>7</sub>, R<sub>a</sub>, R<sub>9</sub>, R,<sub>o</sub>, R<sub>11</sub>, R<sub>12</sub>, R<sub>13</sub>, R<sub>15</sub>, R<sub>18</sub>, R<sub>19</sub>, R<sub>20</sub>, R<sub>21</sub> and R<sub>26</sub> are different from the residues appearing in that respective position in the native molecule. These peptides as well as non- toxic salts thereof may be administered to animals, including humans and cold-blooded animals, to stimulate the release of GH and may be used diagnostically.
Patent IL-94724-A0 (IL)
Title: Lysis of red blood cells and hemoglobin denaturing by the use of lithium salts
IPC: G01N33/53
Filed: 1990-06-13
Abstract: Use of a lithium salt, particularly lithium thiocyanate, as an agent for lysing red blood cells and denaturing hemoglobin in the performance of an immunoassay to detect the relative amount of a hemoglobin derivative in a blood sample. The method is particularly useful in the determination of hemoglobin A1c. The method provides a rapid means for releasing hemoglobin from red blood cells by lysis and for exposing the epitope that is characteristic of the A1c form. Low concentrations of the lithium salt provide rapid release and denaturation of hemoglobin without the need for dilution prior to the performance of the immunoassay.
Patent IL-97335-A0 (IL)
Title: Electrochromic,electroluminescent and electrochemiluminescent displays
IPC: C09K9/00
Filed: 1991-02-22
Abstract: A display having an array of matrix addressable pairs of electrodes mounted face up on the same substrate. The pairs of electrodes are derivatized with either electrochromic materials or electroluminescent material to form the pixels of the display. In the electrochromic embodiment of the invention, a layer of a solid polymer electrolyte is included. The air of electrodes may also be left clean of derivatizing material, but with an electroluminescent substance dissolved in the solid polymer electrolyte. An electrochemiluminescent embodiment is also provided where the electrochemiluminescent substance can be dissolved in the solid polymer electrolyte. A method of patterning the electrolyte layer to form relatively nonconductive borders around each of the pairs by selective exposure of the electrolyte layer in the region of the border to electromagnetic radiation to cause permanent change in the chemical composition of the electrolyte so that the exposed border regions are rendered relatively non-conductive is also provided. An electrically reconfigurable photomask having an area comprised of an arrangement of electrochromic covered electrode pairs constituting pixels, the opacity and transmissivity of which may be controlled by application of an electrical bias to yield complete control over the transmissivity and opacity of each pixel of the areas, is also provided.
Patent IL-97803-A0 (IL)
Title: Plasmids containing dna sequences for modifying plant cell characteristics and plant cells containing the same
IPC: C12N15/29
Filed: 1991-04-09
Abstract: Plasmids are described, the DNA sequences of which when inserted into the genome of a plant modify the carbohydrate or protein concentration and the carbohydrate or protein composition, as well as plant cells and plants that contain those plasmids. DNA located in plasmids described reduces in the plant the ADP-glucose-pyrophosphorylase activity and thereby the starch concentration and at the same time increases the mono- and oligosaccharide concentration. Other DNA in plasmids reduces or increases the protein concentration. Plants that contain those plasmids are suitable inter alia for the extraction of sugar or as protein-enriched food or fodder.
Patent IL-98626-A0 (IL)
Title: O-benzyloxime ethers and fungicidal compositions containing them
IPC: A01N37/52
Filed: 1991-06-26
Abstract: N-Phthaloyl-O-benzyl oxime ethers (I) are new. X = CH2, CH(1-4C alkyl), CH(1-4C alkoxy), CH(1-4C alkylthio or N(1-4C alkoxy); Y = O, S or NR4; Z1, Z2 = H, halogen, methyl, methoxy or cyano; R1, R2, R4 = H or 1-4C alkyl; R3 = H, halogen, cyano, nitro or opt. substd. 1-4C alkyl, 1-4C alkoxy, 1-4C haloalkyl, 1-4C haloalkoxy, aryl, aryloxy, benzyloxy, heteroaryl or heteroaryloxy; n = 1-4.
Patent AU-PO879497-A0 (AU)
Title: Pump impeller and method
IPC: F04D29/28
Filed: 1997-08-26
Abstract: A pump impeller which is modified so as to achieve selected operating performance parameters. The impeller includes a front shroud and a rear shroud, the shrouds being spaced apart so as to form a plurality of passageways therebetween which are separated by a plurality of impeller blades, each having an outer edge extending between the front and rear shrouds, the impeller having an outer diameter D. The method modification includes the steps of trimming the outer edge of the blades so that the outer diameter D1 of the front shroud is less than the outer diameter D2 of the rear shroud.
Patent IL-107360-A0 (IL)
Title: Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for the preparation thereof
IPC: A61K9/70
Filed: 1993-10-21
Abstract: The invention relates to a patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature which comprises a multi-element system comprising   (a) a matrix having distributed therein as the drug said volatile active ingredient or a physiologically acceptable salt thereof, the matrix comprising a pressure-sensitive adhesive, (b) an element of a pressure-sensitive adhesive composition which - where (a) contains a salt - contains basic groups to liberate the free base from its salt, (c) a backing layer impermeable to the diffusable ingredients of (a) and (b), and (d) a release liner impermeable to the diffusable ingredients of (a) and (b), matrix (a) or at least a part of (b), whichever is in contact with release liner (d), having a tack sufficient for affixing the patch to the skin, any part of (b) positioned between matrix (a) and release liner (d) being permeable for the deprenyl or the salt thereof or both. The invention also relates to a process for preparing such patch. <IMAGE>
Patent IL-108468-A0 (IL)
Title: Ventilation installation
IPC: F24F13/26
Filed: 1994-01-28
Abstract: PCT No. PCT/EP94/00256 Sec. 371 Date Jul. 27, 1995 Sec. 102(e) Date Jul. 27, 1995 PCT Filed Jan. 29, 1994 PCT Pub. No. WO94/18506 PCT Pub. Date Aug. 18, 1994The invention relates to a ventilation device. Provision is made that the air propulsion plant (20) conveys at least a portion of the air in an air circulating mode by means of at least one variable volume chamber (6) in a pulsating manner at a very low frequency, with the chamber being connected to the room (2) by at least one air passage (21).
Patent IL-112134-A0 (IL)
Title: Substituted morpholine derivatives, their preparation and pharmaceutical compositions containing them
IPC: A61K31/5377
Filed: 1994-12-23
Abstract: The present invention relates to compounds of the formula (I): <CHEM> wherein R<1> is hydrogen, halogen, C1-6alkyl, C1-6alkoxy, CF3, NO2, CN, SR<a>, SOR<a>, SO2R<a>, CO2R<a>, CONR<a>R<b>, C2-6alkenyl, C2-6alkynyl or C1-4alkyl substituted by C1-4alkoxy, where R<a> and R<b> are hydrogen or C1-4alkyl; R<2> is hydrogen, halogen, C1-6alkyl, C1-6alkoxy substituted by C1-4alkoxy or CF3; R<3> is hydrogen, halogen or CF3; R<4> is selected from the definitions of R<1>; R<5> is selected from the definitions of R<2>; R<6> is a 5-membered or 6-membered heterocyclic ring containing 2 or 3 nitrogen atoms optionally substituted by =O or =S and optionally substituted by an aminoalkyl group; R<9a> and R<9b> are hydrogen or C1-4alkyl, or R<9a> and R<9b> are joined to form a C5-7 ring; X is C1-4alkylene optionally substituted by oxo; and Y is a C1-4alkyl group substituted by hydroxyl; and pharmaceutically acceptable salts and prodrugs thereof. <??>The compounds are of particular use in the treatment of pain, inflammation, migraine and emesis.
Patent IL-115691-A0 (IL)
Title: Model predictive control apparatus and method
IPC: G05B13/04
Filed: 1995-10-19
Abstract: A model predictive control apparatus and method for controlling the operation of a process having a process input signal and a process output signal, which includes determining a predicted process output signal at a future steady state condition according to a process model, determining a steady state error signal according to the difference between the predicted process output signal and a desired set point signal, and determining a set of future process input change signals required to correct for the estimated steady state error by providing at least one step response in the process output at a future time. The next net process input change is then applied according to the sum of the currently determined first element of the set of future process input change signals summed with any future process input change signals that were previously calculated for the next process input change signal that is calculated according to this method. The model is expressed in velocity form. Process tuning parameters are available to dampen the net process input change as well as the currently determined first element of the process input change with respect to a process input change signal that is calculated according to the steady state error divided by the steady state process gain.
Patent IL-123741-A0 (IL)
Title: Pressure-sensitive hot-melt adhesive composition
IPC: A61F13/15
Filed: 1998-03-19
Abstract: The present invention relates to a pressure-sensitive hot-melt adhesive composition characterized in that it includes a) at least one ethylene-alkyl acrylate copolymer, b) a tackifying resin and c) optionally a diluent and/or a stabilizer and/or a wax. Such a composition may be employed advantageously in the field of hygiene, especially for the adhesive bonding of disposable nappies and of catamenial liners.
Patent IL-132305-A0 (IL)
Title: Computerized emg diagnostic system
Filed: 1998-04-14
Abstract: A generally flat, rectangular rubber pad supports (63) discrete, non-invasive electrodes in a 7 by 9 array and a ground electrode to collect surface electromyographic (EMG) signals from an underlying muscle group of a patient. Electronic apparatus conditions the EMG signals and is programmed to survey the electrode array simultaneously to provide a description of the activity of individual muscles in the muscle group at that point in time. The description is displayed on a video monitor or the like, juxtaposed over a display of normal muscle anatomy, with differences being emphasized by color enhancement. The electrode pad is particularly suited for the lower back muscle groups and may be retained in position by a lumbar support belt having a pad molded to the contours of the human spine.
Patent IL-140174-A0 (IL)
Title: Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device
Inventor: HANNI CLAUDE
IPC: G01N33/487
Filed: 1999-06-04
Abstract: The invention concerns a device comprising a support (11) in the thickness of which is produced a supply chamber (12) with an inlet duct (13) for nutrient liquid and a discharge duct (14) for said liquid. A capsule (22) capable of receiving organic cells is provided on the support (11). The supply chamber (12) and the support (11) are separated by a porous membrane (16) comprising an array of electrodes (17) arranged so as to be in contact with different zones of the group of cells, thereby enabling their electrophysiological activity to be analyzed. The device enables to increase the life span of cells and to carry out analyses simply and without affecting the cell organization.
Patent IL-141017-A0 (IL)
Title: Dispersion and stabilization of reactive atoms on the surface of metal oxides
IPC: C07C2/72
Filed: 1999-08-12
Abstract: Particulate metal oxide compositions having reactive halogen atoms stabilized on particulate surfaces and methods for reacting the compositions with saturated and unsaturated species are provided. The preferred particulate metal oxides of the compositions are nanocrystalline MgO and CaO with average crystallite size of up to about 20 nm. The preferred reactive atoms of the compositions are atoms of chlorine. In one embodiment, chloride atoms are stabilized on the surface of nanocrystalline MgO thus forming a composition which is capable of halogenating compounds, both saturated and unsaturated, in the absence of UV light and elevated reaction temperatures.
Patent IL-144460-A0 (IL)
Title: Inhibitors for use in hemostasis and immune function
IPC: A61P17/02
Filed: 2000-02-17
Abstract: The invention provides uses for adipocyte complement related protein in the manufacture of pharmaceuticals for minimizing vascular occlusion, inducing vasodilation and enhancing the progression of wound healing in mammals. A preferred amino acid sequence for the adipocyte complement related protein is provided. The invention demonstrates particular utility in treating cases of vascular injury arising from surgery or trauma. <IMAGE>
Patent IL-147662-A0 (IL)
Title: Dental implant comprising two biocompatible materials
Inventor: FROMENTAL ROBERT
IPC: A61C8/00
Filed: 2000-07-12
Abstract: The invention concerns a dental implant made of a first metal, comprising an external coating layer (13) and a second porous metal. The first metal is a shape-memory titanium alloy, preferably a Ti-Ni, Ti-Ni-Co or Ti-Ni-Fe alloy. The second porous metal is titanium, a titanium alloy, preferably a Ti-Ni, Ti-Ni-Co or Ti-Ni-Fe alloy having 20 % to 50 % open porosity and pore dimensions of 50 to 400 microns. The invention is useful for producing a dental prosthesis.
Patent IL-152620-A0 (IL)
Title: Affinity selected signature peptides for protein identification and quantification
IPC: G01N30/88
Filed: 2001-05-04
Abstract: A method for protein identification in complex mixtures that utilizes affinity selection of constituent proteolytic peptide fragments unique to a protein analyte. These “signature peptides” function as analytical surrogates. Mass spectrometric analysis of the proteolyzed mixture permits identification of a protein in a complex sample without purifying the protein or obtaining its composite peptide signature.
Patent IL-155669-A0 (IL)
Title: Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
IPC: A61P31/04
Filed: 2001-12-19
Abstract: An efficient deoximation technique for use in synthesis of erythromycin derivatives, involving aryl thioimine intermediates is disclosed. The aryl thioimine intermediates can be utilized in a method for protecting a ketone of a ketone-containing erythromycin derivative as a thioimine; a method for deoximating an oxime-containing erythromycin derivative, or a method for preparing a 6-O-alkyl erythromycin derivative. Presently preferred erythromycin derivatives have a C-9 oxime or a C-9 ketone.
Patent IL-160041-A0 (IL)
Title: Electromagnetic coupling
IPC: H01P1/06
Filed: 2002-11-18
Abstract: An orthogonal electrical coupling relies on electromagnetic coupling for the inner connection, as opposed to direct contact between conductors. A conductor on one of the lines is connected to a ground plane which is adjacent to a resonant slot. Microwave energy is coupled to the slot, thereby exciting the slot. A second conductor is on the opposite side of the ground plane from the first conductor. Microwave energy from the excited resonant slot passes to the second conductor, thereby allowing contactless interconnection between the first conductor and the second conductor. The coupling may emphasize certain modes of propagation relative to other possible modes of propagation. Specifically, the ground plane and slot may be enclosed in a cavity of a size such that the cavity does not support any natural mode propagation inside the cavity. Instead, the coupling may have a cavity in which a transverse electromagnetic (TEM) mode is propagated.
Patent IL-173520-A0 (IL)
Title: Method for the production of dual-layer slab or board-like articles and slab or board-like articles which can be obtained by the method
IPC: B29C67/24
Filed: 2006-02-02
Abstract: "Bretonstone" technology is used for the production of a dual-layer slab or board-like article. The rear layer is formed from a mix comprising an inorganic granular material in expanded form, in particular consisting of beads of expanded glass, expanded day and the like, a filler in the form of a fine powder, preferably cristobalite, and a hardening resin, in particular epoxy resin or polyester. The first layer, which is intended to form the visible side of the article, comprises the same resin or a resin compatible with that present in said rear layer. A web of continuous glass filaments is arranged between the said two layers. The invention also relates to the article or slab which can be obtained by the abovementioned method.
Patent IL-177243-A0 (IL)
Title: Extended release coated minitablets of venlafaxine hydrochloride
IPC: A61K31/137
Filed: 2006-08-02
Abstract: The present invention relates to an extended release once daily pharmaceutical formulation comprising venlafaxine hydrochloride and pharmaceutically acceptable excipients. More particularly, the present invention relates to an extended release composition in the form of mini-tablets which are incorporated in hard gelatin capsules.
Patent IL-177705-A0 (IL)
Title: Detection of human papillomavirus
IPC: C12Q1/68
Filed: 2006-08-24
Abstract: The present invention relates to in vitro methods of screening human subjects for the presence of human papillomavirus (HPV) which exhibits loss of regulation of E6/E7 mRNA expression and loss of replication and/or expression of a stabilized pre-mRNA encoding full length E6 protein. In particular, the invention provides in vitro methods of screening for persistent transforming HPV infection equivalent to persistent cell abnormalities or persistent CIN III lesions, cancer in situ or high-grade squamous intraepithelial lesions (HSIL). The methods are useful in the context of cervical cancer screening.
Patent IL-186069-A0 (IL)
Title: Surgical stapling instrument having an electroactive polymer actuated single lockout mechanism for prevention of firing
IPC: A61B17/072
Filed: 2007-09-19
Abstract: A surgical instrument includes an E-beam firing bar engages the channel and selectively engages the anvil during distal firing movements, wherein the tissue is severed and stapled driven upward from the staple cartridge to form against the anvil. In particular, a wedge integral to the staple cartridge is driven distally by a middle pin of the firing bar to effect stapling. A single lockout of the staple channel responds to the presence of the wedge sled in its unfired position to allow the firing bar to fire. Otherwise, the single lockout prevents firing when the staple cartridge is missing or spent. Further, some versions include an Electroactive Polymer (EAP) actuator that presents an abutting surface, or acts as a trapdoor to a ramped recess in a staple channel to block the firing bar, as an active approach to preventing firing for one or more conditions.